Fly News Breaks for March 5, 2015
EKSO
Mar 5, 2015 | 08:16 EDT
Ladenburg started shares of Ekso Bionics with a Buy rating and $3.50 price target saying the company is positioned as the current and future leader for exoskeletal related technologies. The firm expects Ekso's rehabilitation products continue to penetrate the market in 2015.
News For EKSO From the Last 2 Days
There are no results for your query EKSO